Anthera amends IPO

Anthera Pharmaceuticals Inc. (Hayward, Calif.) raised the number of shares and lowered the proposed price of its IPO. The company now hopes to sell 6 million shares at $7 instead of 4.6 million shares at $13-$15. A $7 price would raise $42 million and value the company at $151.1 million. At the $14 mid-point of the prior range and 4.6 million shares, the company would have raised $64.5 million and been valued at $242.2 million. Anthera originally filed in September to raise up to $70 million. Deutsche Bank; Piper Jaffray; Cowen; and Merriman Curhan Ford are the underwriters. ...